Abstract
Purpose of review
The goal of this review is to provide an actualized overview on vestibular migraine in childhood and adolescence, with focus on the epidemiology and clinical presentation as well as its treatment.
Recent findings
Vertigo spells in childhood can evolve into other periodic syndromes and/or migraine types and persist even into adulthood.
Summary
Vestibular migraine (VM) and benign paroxysmal vertigo are the most common causes of vertigo in children and adolescents. The diagnostic criteria for VM are dizziness and vertigo, headache, phonophobia and photophobia, and visual aura. The prevention of attacks is the treatment for children and adolescents with VM, as is recommended for migraine with or without aura. Thus, non-pharmacological measures are the first-line option; when these measures fail or daily activities are notably affected, drugs are administrated. Psychological assessment and cognitive behavioral therapy are also important therapeutic measures in this patient group. There is still insufficient research on VM in children and adolescents; future studies on clinical presentation, evolvement, and specific treatment are necessary.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Neuhauser H, Leopold M, von Brevern M, Arnold G, Lempert T. The interrelations of migraine, vertigo, and migrainous vertigo. Neurology. 2001;56(4):436–41.
Neuhauser HK, Radtke A, von Brevern M, Feldmann M, Lezius F, Ziese T, et al. Migrainous vertigo: prevalence and impact on quality of life. Neurology. 2006;67(6):1028–33.
•• Dieterich M, Obermann M, Celebisoy N. Vestibular migraine: the most frequent entity of episodic vertigo. J Neurol. 2016;263 Suppl 1:82–9. An actualized and comprehensive review on pathophysiology, clinical characteristics, differential diagnosis, and treatment of VM.
Gruber M, Cohen-Kerem R, Kaminer M, Shupak A. Vertigo in children and adolescents: characteristics and outcome. ScientificWorldJournal. 2012;2012:109624.
Szirmai A. Vestibular disorders in childhood and adolescents. Eur Arch Otorhinolaryngol. 2010;267(11):1801–4.
Niemensivu R, Kentala E, Wiener-Vacher S, Pyykko I. Evaluation of vertiginous children. Eur Arch Otorhinolaryngol. 2007;264(10):1129–35.
Wiener-Vacher SR. Vestibular disorders in children. Int J Audiol. 2008;47(9):578–83.
• Gioacchini FM, Alicandri-Ciufelli M, Kaleci S, Magliulo G, Re M. Prevalence and diagnosis of vestibular disorders in children: a review. Int J Pediatr Otorhinolaryngol. 2014;78(5):718–24. The most recent review on vestibular syndromes in childhood.
• Langhagen T, Lehrer N, Borggraefe I, Heinen F, Jahn K. Vestibular migraine in children and adolescents: clinical findings and laboratory tests. Front Neurol. 2014;5:292. The first report on clinical findings and laboratory test in children and adolescents suffering from VM according to the current diagnostic criteria.
Cutrer FM, Baloh RW. Migraine-associated dizziness. Headache. 1992;32(6):300–4.
Cass SP, Furman JM, Ankerstjerne K, Balaban C, Yetiser S, Aydogan B. Migraine-related vestibulopathy. Ann Otol Rhinol Laryngol. 1997;106(3):182–9.
Reploeg MD, Goebel JA. Migraine-associated dizziness: patient characteristics and management options. Otol Neurotol. 2002;23(3):364–71.
Vukovic V, Plavec D, Galinovic I, Lovrencic-Huzjan A, Budisic M, Demarin V. Prevalence of vertigo, dizziness, and migrainous vertigo in patients with migraine. Headache. 2007;47(10):1427–35.
Langhagen T, Schroeder AS, Rettinger N, Borggraefe I, Jahn K. Migraine-related vertigo and somatoform vertigo frequently occur in children and are often associated. Neuropediatrics. 2013;44(1):55–8.
•• Headache Classification Committee of the International Headache S. The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013;33(9):629–808. The most recent version of the International Headache Classification that provides diagnostic criteria for VM and BVP.
Kayan A, Hood JD. Neuro-otological manifestations of migraine. Brain. 1984;107(Pt 4):1123–42.
Huppert D, Brandt T. Descriptions of vestibular migraine and Meniere’s disease in Greek and Chinese antiquity. Cephalalgia. 2016.
Dieterich M, Brandt T. Episodic vertigo related to migraine (90 cases): vestibular migraine? J Neurol. 1999;246(10):883–92.
•• Lempert T, Olesen J, Furman J, Waterston J, Seemungal B, Carey J, et al. Vestibular migraine: diagnostic criteria. J Vestib Res. 2012;22(4):167–72. The consensus document providing the officially accepted diagnostic criteria for VM.
Casani AP, Dallan I, Navari E, Sellari Franceschini S, Cerchiai N. Vertigo in childhood: proposal for a diagnostic algorithm based upon clinical experience. Acta Otorhinolaryngol Ital. 2015;35(3):180–5.
Radtke A, Neuhauser H, von Brevern M, Hottenrott T, Lempert T. Vestibular migraine—validity of clinical diagnostic criteria. Cephalalgia. 2011;31(8):906–13.
von Brevern M, Neuhauser H. Epidemiological evidence for a link between vertigo and migraine. J Vestib Res. 2011;21(6):299–304.
Neuhauser HK, Lempert T. Diagnostic criteria for migrainous vertigo. Acta Otolaryngol. 2005;125(11):1247–8.
Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society. Cephalalgia. 1988;8 Suppl 7:1–96.
Headache Classification Subcommittee of the International Headache S. The International Classification of Headache Disorders: 2nd edition. Cephalalgia. 2004;24 Suppl 1:9–160.
• Gelfand AA. Episodic syndromes that may be associated with migraine: A.K.A. “the childhood periodic syndromes”. Headache. 2015;55(10):1358–64. A short and comprehensive review on childhood periodic syndromes.
Basser LS. Benign paroxysmal vertigo of childhood. (A variety of vestibular neuronitis). Brain. 1964;87:141–52.
•• Marcelli V, Russo A, Cristiano E, Tessitore A. Benign paroxysmal vertigo of childhood: a 10-year observational follow-up. Cephalalgia. 2015;35(6):538–44. A recent observational study that shows how BPV can evolve into migraine and how vestibular and cochlear systems are affected.
Krams B, Echenne B, Leydet J, Rivier F, Roubertie A. Benign paroxysmal vertigo of childhood: long-term outcome. Cephalalgia. 2011;31(4):439–43.
Lindskog U, Odkvist L, Noaksson L, Wallquist J. Benign paroxysmal vertigo in childhood: a long-term follow-up. Headache. 1999;39(1):33–7.
• Li CM, Hoffman HJ, Ward BK, Cohen HS, Rine RM. Epidemiology of dizziness and balance problems in children in the United States: a population-based study. J Pediatr. 2016;171:240–7 e3. Most recent and large epidemiological report on dizziness and vertigo in childhood.
Humphriss RL, Hall AJ. Dizziness in 10 year old children: an epidemiological study. Int J Pediatr Otorhinolaryngol. 2011;75(3):395–400.
Li Z, Xu Z, Chen Y, Wang Z, He Y, Chun Yu X, et al. An epidemiologic study of vertigo among middle school students in the city of Xiran. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2010;24(16):730–2.
Balatsouras DG, Kaberos A, Assimakopoulos D, Katotomichelakis M, Economou NC, Korres SG. Etiology of vertigo in children. Int J Pediatr Otorhinolaryngol. 2007;71(3):487–94.
Batu ED, Anlar B, Topcu M, Turanli G, Aysun S. Vertigo in childhood: a retrospective series of 100 children. Eur J Paediatr Neurol. 2015;19(2):226–32.
• Brodsky JR, Cusick BA, Zhou G. Evaluation and management of vestibular migraine in children: experience from a pediatric vestibular clinic. Eur J Paediatr Neurol. 2016;20(1):85–92. The first report on management of VM, according to the current diagnostic criteria, in children.
• Lagman-Bartolome AM, Lay C. Pediatric migraine variants: a review of epidemiology, diagnosis, treatment, and outcome. Curr Neurol Neurosci Rep. 2015;15(6):34. Complete and actualized review on all pediatric migraine variants.
Cuenca-Leon E, Corominas R, Fernandez-Castillo N, Volpini V, Del Toro M, Roig M, et al. Genetic analysis of 27 Spanish patients with hemiplegic migraine, basilar-type migraine and childhood periodic syndromes. Cephalalgia. 2008;28(10):1039–47.
Dunn DW, Snyder CH. Benign paroxysmal vertigo of childhood. Am J Dis Child. 1976;130(10):1099–100.
Giffin NJ, Benton S, Goadsby PJ. Benign paroxysmal torticollis of infancy: four new cases and linkage to CACNA1A mutation. Dev Med Child Neurol. 2002;44(7):490–3.
Abu-Arafeh I, Russell G. Paroxysmal vertigo as a migraine equivalent in children: a population-based study. Cephalalgia. 1995;15(1):22–5. Discussion 4.
Neff BA, Staab JP, Eggers SD, Carlson ML, Schmitt WR, Van Abel KM, et al. Auditory and vestibular symptoms and chronic subjective dizziness in patients with Meniere’s disease, vestibular migraine, and Meniere’s disease with concomitant vestibular migraine. Otol Neurotol. 2012;33(7):1235–44.
Eggers SD, Neff BA, Shepard NT, Staab JP. Comorbidities in vestibular migraine. J Vestib Res. 2014;24(5–6):387–95.
Frejo L, Giegling I, Teggi R, Lopez-Escamez JA, Rujescu D. Genetics of vestibular disorders: pathophysiological insights. J Neurol. 2016;263 Suppl 1:45–53.
Johnson GD. Medical management of migraine-related dizziness and vertigo. Laryngoscope. 1998;108(1 Pt 2):1–28.
Marcus DA, Furman JM, Balaban CD. Motion sickness in migraine sufferers. Expert Opin Pharmacother. 2005;6(15):2691–7.
Baloh RW. Neurotology of migraine. Headache. 1997;37(10):615–21.
Boldingh MI, Ljostad U, Mygland A, Monstad P. Vestibular sensitivity in vestibular migraine: VEMPs and motion sickness susceptibility. Cephalalgia. 2011;31(11):1211–9.
Henriques IF, Douglas de Oliveira DW, Oliveira-Ferreira F, Andrade PM. Motion sickness prevalence in school children. Eur J Pediatr. 2014;173(11):1473–82.
Barabas G, Matthews WS, Ferrari M. Childhood migraine and motion sickness. Pediatrics. 1983;72(2):188–90.
Szirmai A. Vestibular disorders in patients with migraine. Eur Arch Otorhinolaryngol. 1997;254 Suppl 1:S55–7.
Batuecas-Caletrio A, Martin-Sanchez V, Cordero-Civantos C, Guardado-Sanchez L, Marcos MR, Fabian AH, et al. Is benign paroxysmal vertigo of childhood a migraine precursor? Eur J Paediatr Neurol. 2013;17(4):397–400.
Radtke A, von Brevern M, Neuhauser H, Hottenrott T, Lempert T. Vestibular migraine: long-term follow-up of clinical symptoms and vestibulo-cochlear findings. Neurology. 2012;79(15):1607–14.
Marcelli V, Furia T, Marciano E. Vestibular pathways involvement in children with migraine: a neuro-otological study. Headache. 2010;50(1):71–6.
Katsanis J, Iacono WG, Harris M. Development of oculomotor functioning in preadolescence, adolescence, and adulthood. Psychophysiology. 1998;35(1):64–72.
Ingster-Moati I, Vaivre-Douret L, Bui Quoc E, Albuisson E, Dufier JL, Golse B. Vertical and horizontal smooth pursuit eye movements in children: a neuro-developmental study. Eur J Paediatr Neurol. 2009;13(4):362–6.
Shin JE, Kim CH, Park HJ. Vestibular abnormality in patients with Meniere’s disease and migrainous vertigo. Acta Otolaryngol. 2013;133(2):154–8.
Boldingh MI, Ljostad U, Mygland A, Monstad P. Comparison of interictal vestibular function in vestibular migraine vs migraine without vertigo. Headache. 2013;53(7):1123–33.
Chang CH, Young YH. Caloric and vestibular evoked myogenic potential tests in evaluating children with benign paroxysmal vertigo. Int J Pediatr Otorhinolaryngol. 2007;71(3):495–9.
O’Reilly RC, Greywoode J, Morlet T, Miller F, Henley J, Church C, et al. Comprehensive vestibular and balance testing in the dizzy pediatric population. Otolaryngol Head Neck Surg. 2011;144(2):142–8.
Firat Y, Ozturan O, Bicak U, Yakinci C, Akarcay M. Auditory brainstem response in pediatric migraine: during the attack and asymptomatic period. Int J Pediatr Otorhinolaryngol. 2006;70(8):1431–8.
Zhang D, Fan Z, Han Y, Wang M, Xu L, Luo J, et al. Benign paroxysmal vertigo of childhood: diagnostic value of vestibular test and high stimulus rate auditory brainstem response test. Int J Pediatr Otorhinolaryngol. 2012;76(1):107–10.
Eckhardt-Henn A, Best C, Bense S, Breuer P, Diener G, Tschan R, et al. Psychiatric comorbidity in different organic vertigo syndromes. J Neurol. 2008;255(3):420–8.
Balaban CD, Jacob RG, Furman JM. Neurologic bases for comorbidity of balance disorders, anxiety disorders and migraine: neurotherapeutic implications. Expert Rev Neurother. 2011;11(3):379–94.
Furman JM, Balaban CD, Jacob RG, Marcus DA. Migraine-anxiety related dizziness (MARD): a new disorder? J Neurol Neurosurg Psychiatry. 2005;76(1):1–8.
Lee CH, Lee SB, Kim YJ, Kong WK, Kim HM. Utility of psychological screening for the diagnosis of pediatric episodic vertigo. Otol Neurotol. 2014;35(10):e324–30.
• Reale L, Guarnera M, Grillo C, Maiolino L, Ruta L, Mazzone L. Psychological assessment in children and adolescents with benign paroxysmal vertigo. Brain Dev. 2011;33(2):125–30. A study that demonstrates that children and adolescents with episodic vertigo should be screened for possible psychological symptoms.
Balaban CD. Migraine, vertigo and migrainous vertigo: links between vestibular and pain mechanisms. J Vestib Res. 2011;21(6):315–21.
Furman JM, Balaban CD. Vestibular migraine. Ann N Y Acad Sci. 2015;1343:90–6.
• Furman JM, Marcus DA, Balaban CD. Vestibular migraine: clinical aspects and pathophysiology. Lancet Neurol. 2013;12(7):706–15. A comprehensive and detailed review on clinical presentation and probable pathophysiology of VM.
Ahn SK, Balaban CD. Distribution of 5-HT1B and 5-HT1D receptors in the inner ear. Brain Res. 2010;1346:92–101.
Dieterich M, Brandt T. Functional brain imaging of peripheral and central vestibular disorders. Brain. 2008;131(Pt 10):2538–52.
Fasold O, von Brevern M, Kuhberg M, Ploner CJ, Villringer A, Lempert T, et al. Human vestibular cortex as identified with caloric stimulation in functional magnetic resonance imaging. Neuroimage. 2002;17(3):1384–93.
Bucher SF, Dieterich M, Wiesmann M, Weiss A, Zink R, Yousry TA, et al. Cerebral functional magnetic resonance imaging of vestibular, auditory, and nociceptive areas during galvanic stimulation. Ann Neurol. 1998;44(1):120–5.
Shin JH, Kim YK, Kim HJ, Kim JS. Altered brain metabolism in vestibular migraine: comparison of interictal and ictal findings. Cephalalgia. 2014;34(1):58–67.
Brandt T, Bartenstein P, Janek A, Dieterich M. Reciprocal inhibitory visual-vestibular interaction. Visual motion stimulation deactivates the parieto-insular vestibular cortex. Brain. 1998;121(Pt 9):1749–58.
Russo A, Marcelli V, Esposito F, Corvino V, Marcuccio L, Giannone A, et al. Abnormal thalamic function in patients with vestibular migraine. Neurology. 2014;82(23):2120–6.
Obermann M, Wurthmann S, Steinberg BS, Theysohn N, Diener HC, Naegel S. Central vestibular system modulation in vestibular migraine. Cephalalgia. 2014;34(13):1053–61.
Marano E, Marcelli V, Di Stasio E, Bonuso S, Vacca G, Manganelli F, et al. Trigeminal stimulation elicits a peripheral vestibular imbalance in migraine patients. Headache. 2005;45(4):325–31.
Lewis RF, Priesol AJ, Nicoucar K, Lim K, Merfeld DM. Abnormal motion perception in vestibular migraine. Laryngoscope. 2011;121(5):1124–5.
Moskowitz MA. Pathophysiology of headache—past and present. Headache. 2007;47 Suppl 1:S58–63.
Vass Z, Shore SE, Nuttall AL, Miller JM. Direct evidence of trigeminal innervation of the cochlear blood vessels. Neuroscience. 1998;84(2):559–67.
Ophoff RA, Terwindt GM, Vergouwe MN, van Eijk R, Oefner PJ, Hoffman SM, et al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell. 1996;87(3):543–52.
Kim JS, Yue Q, Jen JC, Nelson SF, Baloh RW. Familial migraine with vertigo: no mutations found in CACNA1A. Am J Med Genet. 1998;79(2):148–51.
von Brevern M, Ta N, Shankar A, Wiste A, Siegel A, Radtke A, et al. Migrainous vertigo: mutation analysis of the candidate genes CACNA1A, ATP1A2, SCN1A, and CACNB4. Headache. 2006;46(7):1136–41.
Neuhauser H, Radtke A, von Brevern M, Lempert T. Zolmitriptan for treatment of migrainous vertigo: a pilot randomized placebo-controlled trial. Neurology. 2003;60(5):882–3.
• Richer L, Billinghurst L, Linsdell MA, Russell K, Vandermeer B, Crumley ET, et al. Drugs for the acute treatment of migraine in children and adolescents. Cochrane Database Syst Rev. 2016;4:CD005220. A systematic review and meta-analysis of drugs for the acute treatment of migraine in children and adolescents.
• Patniyot IR, Gelfand AA. Acute treatment therapies for pediatric migraine: a qualitative systematic review. Headache. 2016;56(1):49–70. A complete and comprehensive review on safety and efficacy of acute treatment options for pediatric migraine.
Maldonado Fernandez M, Birdi JS, Irving GJ, Murdin L, Kivekas I, Strupp M. Pharmacological agents for the prevention of vestibular migraine. Cochrane Database Syst Rev. 2015;6, CD010600.
Vitkovic J, Winoto A, Rance G, Dowell R, Paine M. Vestibular rehabilitation outcomes in patients with and without vestibular migraine. J Neurol. 2013;260(12):3039–48.
• Kacperski J. Prophylaxis of migraine in children and adolescents. Paediatr Drugs. 2015;17(3):217–26. A complete and comprehensive review on prophylaxis of migraine in children and adolescents.
Eidlitz-Markus T, Haimi-Cohen Y, Steier D, Zeharia A. Effectiveness of nonpharmacologic treatment for migraine in young children. Headache. 2010;50(2):219–23.
Bruni O, Galli F, Guidetti V. Sleep hygiene and migraine in children and adolescents. Cephalalgia. 1999;19 Suppl 25:57–9.
Millichap JG, Yee MM. The diet factor in pediatric and adolescent migraine. Pediatr Neurol. 2003;28(1):9–15.
Blume HK, Brockman LN, Breuner CC. Biofeedback therapy for pediatric headache: factors associated with response. Headache. 2012;52(9):1377–86.
Ernst MM, O’Brien HL, Powers SW. Cognitive-behavioral therapy: how medical providers can increase patient and family openness and access to evidence-based multimodal therapy for pediatric migraine. Headache. 2015;55(10):1382–96.
Trautmann E, Lackschewitz H, Kroner-Herwig B. Psychological treatment of recurrent headache in children and adolescents—a meta-analysis. Cephalalgia. 2006;26(12):1411–26.
• Hickman C, Lewis KS, Little R, Rastogi RG, Yonker M. Prevention for pediatric and adolescent migraine. Headache. 2015;55(10):1371–81. Provides a systematic review on prevention for pediatric and adolescent migraine.
Hershey AD, Powers SW, Coffey CS, Eklund DD, Chamberlin LA, Korbee LL, et al. Childhood and Adolescent Migraine Prevention (CHAMP) study: a double-blinded, placebo-controlled, comparative effectiveness study of amitriptyline, topiramate, and placebo in the prevention of childhood and adolescent migraine. Headache. 2013;53(5):799–816.
Hershey AD, Powers SW, Vockell AL, Lecates SL, Ellinor PL, Segers A, et al. Coenzyme Q10 deficiency and response to supplementation in pediatric and adolescent migraine. Headache. 2007;47(1):73–80.
Slater SK, Nelson TD, Kabbouche MA, LeCates SL, Horn P, Segers A, et al. A randomized, double-blinded, placebo-controlled, crossover, add-on study of CoEnzyme Q10 in the prevention of pediatric and adolescent migraine. Cephalalgia. 2011;31(8):897–905.
Condo M, Posar A, Arbizzani A, Parmeggiani A. Riboflavin prophylaxis in pediatric and adolescent migraine. J Headache Pain. 2009;10(5):361–5.
Wang F, Van Den Eeden SK, Ackerson LM, Salk SE, Reince RH, Elin RJ. Oral magnesium oxide prophylaxis of frequent migrainous headache in children: a randomized, double-blind, placebo-controlled trial. Headache. 2003;43(6):601–10.
Acknowledgments
We would like to thank Judy Benson for copyediting the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
This project was supported by funds from the German Federal Ministry of Education and Research (BMBF) under the Grant code IFB 01EO1401.
Conflict of Interest
Thyra Langhagen, Mirjam N. Landgraf, Doreen Huppert, Florian Heinen, and Klaus Jahn declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
This article is part of the Topical Collection on Childhood and Adolescent Headache
Rights and permissions
About this article
Cite this article
Langhagen, T., Landgraf, M.N., Huppert, D. et al. Vestibular Migraine in Children and Adolescents. Curr Pain Headache Rep 20, 67 (2016). https://doi.org/10.1007/s11916-016-0600-x
Published:
DOI: https://doi.org/10.1007/s11916-016-0600-x